Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Dec 27, 2021; 13(12): 1597-1614
Published online Dec 27, 2021. doi: 10.4240/wjgs.v13.i12.1597
Published online Dec 27, 2021. doi: 10.4240/wjgs.v13.i12.1597
Table 1 Individualized response prediction in patients with hepatic artery infusion[42]
| Response predictor | Clinical outcome | Median survival (mo, range) | |
| Beneficial response (%) | No response (%) | ||
| HTCA | |||
| Sensitive | 58 | 42 | 28 (3-75) |
| Resistant | 33 | 67 | 19 (5-48) |
| TS | |||
| Sensitive | 64 | 36 | 26 (6-48) |
| Resistant | 20 | 80 | 26 (3-75) |
| HTCA + TS | |||
| Sensitive | 77 | 23 | 32 (5-75) |
| Resistant | 9 | 91 | 17 (3-28) |
- Citation: Link KH, Kornmann M, Staib L, Kreuser ED, Gaus W, Röttinger E, Suhr P, Maulbecker-Armstrong C, Danenberg P, Danenberg K, Schatz M, Sander S, Ji ZL, Li JT, Peng SY, Bittner R, Beger HG, Traub B. Patient-centered developments in colon- and rectal cancer with a multidisciplinary international team: From translational research to national guidelines. World J Gastrointest Surg 2021; 13(12): 1597-1614
- URL: https://www.wjgnet.com/1948-9366/full/v13/i12/1597.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i12.1597